EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bilateral renal agenesis: fetal intervention and outcomes

Katherine Jones, Amaris M Keiser, Jena L Miller, Meredith A Atkinson

Pediatric Nephrology · 2025

DOI: 10.1007/s00467-024-06449-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Nephrology, 2025. Verfasst von Katherine Jones und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, F. Edward Hébert School of Medicine, Uniformed Services University, Tripler Army Medical Center, 1 Jarrett White Rd., Honol…. Hauptthemen laut MEDLINE: Congenital Abnormalities, Fetal Therapies, Kidney. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bilateral renal agenesis (BRA) is a fetal anomaly which leads to anhydramnios and resultant pulmonary hypoplasia. Historically, this anomaly was universally fatal early in the neonatal period due to the severity of the associated lung disease. Over the last 30 years, innovations in fetal therapies-specifically, serial amnioinfusions-have led to instances of infant pulmonary survival and initiation of postnatal dialysis, raising the possibility that early neonatal death may not be inevitable. Amnioinfusions are not without risk, and maternal complications can include prelabor rupture of membranes, preterm labor, infection, and bleeding. The data detailing neonatal outcomes are still limited and actively being collected. Two case series and one non-randomized clinical trial have supplied most of the known outcome data for infants with BRA after prenatal amnioinfusion. Although there are survivors reported in the literature, mortality remains high, with many deaths in infancy due to dialysis-associated sepsis. In addition, previously unknown morbidities have been documented in these infants, including neurologic injury. These challenges, in addition to the mechanical difficulties of providing dialysis to extremely small infants, can result in significant burdens for patients and their caregivers and moral distress for the health care team. The present review aims to explain the pathophysiology of BRA, detail the historical context and rationale for serial amnioinfusions to treat the pulmonary insufficiency associated with BRA, describe the available data regarding outcomes of infants born following prenatal amnioinfusions, discuss ethical issues surrounding this fetal intervention, and describe critical aspects of prenatal counseling for patients considering the intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Congenital AbnormalitiesFetal TherapiesKidneyFemaleHumansInfant, NewbornPregnancyKidney DiseasesLungRenal DialysisTreatment Outcome

Stichwörter der Autor:innen

Bilateral renal agenesisFetal interventionFetus

Autor:innen und Institutionen

  • Department of Pediatrics, F. Edward Hébert School of Medicine, Uniformed Services University, Tripler Army Medical Center, 1 Jarrett White Rd., Honolulu, HI, 96859, USA. katherine.jones@usuhs.edu.
  • Division of Neonatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Center for Fetal Therapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Division of Pediatric Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Zitieren

APA

Jones, K., Keiser, A. M., Miller, J. L., & Atkinson, M. A. (2025). Bilateral renal agenesis: fetal intervention and outcomes. Pediatric Nephrology. https://doi.org/10.1007/s00467-024-06449-8

Vancouver

Jones K, Keiser AM, Miller JL, Atkinson MA. Bilateral renal agenesis: fetal intervention and outcomes. Pediatric Nephrology. 2025. doi:10.1007/s00467-024-06449-8

BibTeX
@article{Jones2025,
  author = {Jones, Katherine and Keiser, Amaris M and Miller, Jena L and Atkinson, Meredith A},
  title = {Bilateral renal agenesis: fetal intervention and outcomes},
  journal = {Pediatric Nephrology},
  year = {2025},
  doi = {10.1007/s00467-024-06449-8}
}
Kostenlos starten →